arrow
S

Sarah Cappuyns

university hospitals leuven
H指数:8
被引数:413

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma.

髓系免疫抑制表型定义了肝细胞癌对阿替利珠单抗联合贝伐珠单抗的原发耐药性。

2026-06-150
OAAI
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment

解码肿瘤异质性:一项关于肿瘤微环境的基于空间信息的泛癌分析

2025-10-140
OAAI
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
2024-11-010
OAAI
PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
2023-11-2911
OAAI